{"id":"https://openalex.org/W4361255360","doi":"https://doi.org/10.1158/0008-5472.c.6493941.v1","title":"Data from Concurrent Binding of Anti-EphA3 Antibody and Ephrin-A5 Amplifies EphA3 Signaling and Downstream Responses: Potential as EphA3-Specific Tumor-Targeting Reagents","display_name":"Data from Concurrent Binding of Anti-EphA3 Antibody and Ephrin-A5 Amplifies EphA3 Signaling and Downstream Responses: Potential as EphA3-Specific Tumor-Targeting Reagents","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361255360","doi":"https://doi.org/10.1158/0008-5472.c.6493941.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6493941.v1","doi":"https://doi.org/10.1158/0008-5472.c.6493941.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6493941.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6493941.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070635869","display_name":"Christopher Vearing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Vearing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034686081","display_name":"Fook-Thean Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fook-Thean Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051067791","display_name":"Sabine H. Wimmer-Kleikamp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabine Wimmer-Kleikamp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019945834","display_name":"Violeta Spirkoska","orcid":"https://orcid.org/0000-0002-0600-4569","observed_orcids":["https://orcid.org/0000-0002-0600-4569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Violeta Spirkoska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111967626","display_name":"Catherine To","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine To","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073471831","display_name":"Con Stylianou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Con Stylianou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067890038","display_name":"Mark Spanevello","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Spanevello","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002401816","display_name":"Martin W. Brechbiel","orcid":"https://orcid.org/0000-0002-4012-1400","observed_orcids":["https://orcid.org/0000-0002-4012-1400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Brechbiel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090491025","display_name":"Andy Boyd","orcid":"https://orcid.org/0000-0002-8614-3728","observed_orcids":["https://orcid.org/0000-0002-8614-3728"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew W. Boyd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078312966","display_name":"Andrew Mark Scott","orcid":"https://orcid.org/0000-0002-6656-295X","observed_orcids":["https://orcid.org/0000-0002-6656-295X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew M. Scott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078740025","display_name":"Martin Lackmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Lackmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12061","display_name":"Axon Guidance and Neuronal Signaling","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12061","display_name":"Axon Guidance and Neuronal Signaling","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epha3","display_name":"EphA3","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ephrin-a5","display_name":"ephrin-A5","score":0.9779999852180481},{"id":"https://openalex.org/keywords/eph-receptors","display_name":"Eph receptors","score":0.7599999904632568},{"id":"https://openalex.org/keywords/ligand-receptor-interactions","display_name":"ligand-receptor interactions","score":0.5950000286102295},{"id":"https://openalex.org/keywords/receptor-activation","display_name":"receptor activation","score":0.37599998712539673}],"concepts":[{"id":"https://openalex.org/C170286479","wikidata":"https://www.wikidata.org/wiki/Q24787399","display_name":"Ephrin","level":3,"score":0.8915121555328369},{"id":"https://openalex.org/C19331615","wikidata":"https://www.wikidata.org/wiki/Q423602","display_name":"Erythropoietin-producing hepatocellular (Eph) receptor","level":4,"score":0.7731615304946899},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.6028525829315186},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5094886422157288},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4564126133918762},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4519564211368561},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39145252108573914},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36081406474113464},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3273478150367737},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2946740388870239}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6493941.v1","doi":"https://doi.org/10.1158/0008-5472.c.6493941.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6493941.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6493941.v1","doi":"https://doi.org/10.1158/0008-5472.c.6493941.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6493941.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2163513494","https://openalex.org/W2241182964","https://openalex.org/W7099556174","https://openalex.org/W1543363553","https://openalex.org/W2282529604","https://openalex.org/W4411403764","https://openalex.org/W4392679651","https://openalex.org/W3021961078","https://openalex.org/W1568685187","https://openalex.org/W2031984119"],"abstract_inverted_index":{"Abstract":[0],"The":[1,57],"Eph":[2,42],"receptor":[3],"tyrosine":[4],"kinases":[5],"and":[6,21,39,43,104,110,115,145,160,165,171,188,191],"their":[7,163],"membrane-bound":[8],"ephrin":[9,44],"ligands":[10],"form":[11],"a":[12,27,34,71],"unique":[13],"cell-cell":[14],"contact\u2013mediated":[15],"system":[16],"for":[17,54,135],"controlling":[18],"cell":[19,105],"localization":[20],"organization.":[22],"Their":[23],"high":[24],"expression":[25],"in":[26,36,46,149,166],"wide":[28],"variety":[29],"of":[30,101,113,138,158,185],"human":[31,177],"tumors":[32],"indicates":[33],"role":[35],"tumor":[37,197],"progression,":[38],"relatively":[40],"low":[41],"levels":[45],"normal":[47],"tissues":[48],"make":[49],"these":[50],"proteins":[51],"potential":[52,195],"targets":[53],"anticancer":[55],"therapies.":[56],"monoclonal":[58],"antibody":[59],"IIIA4,":[60],"previously":[61],"used":[62],"to":[63,70,82,92],"isolate":[64],"EphA3,":[65],"binds":[66],"with":[67,118],"subnanomolar":[68],"affinity":[69],"conformation-specific":[72],"epitope":[73],"within":[74],"the":[75,83,102,136,182],"ephrin-binding":[76],"domain":[77],"that":[78,90,125,189],"is":[79,133],"closely":[80],"adjacent":[81],"\u201clow-affinity\u201d":[84],"ephrin-A5":[85,120,146,159,190],"heterotetramerization":[86],"site.":[87],"We":[88],"show":[89,181],"similar":[91],"ephrin-A5,":[93],"preclustered":[94],"IIIA4":[95,126,144,161,192],"effectively":[96],"triggers":[97,128],"EphA3":[98,117,130,154],"activation,":[99],"contraction":[100],"cytoskeleton,":[103],"rounding.":[106],"BIAcore":[107],"analysis,":[108],"immunoblot,":[109],"confocal":[111],"microscopy":[112],"wild-type":[114],"mutant":[116],"compromised":[119],"or":[121],"IIIA4-binding":[122],"capacities":[123],"indicate":[124],"binding":[127],"an":[129],"conformation":[131],"which":[132],"permissive":[134],"assembly":[137],"EphA3/ephrin-A5-type":[139],"signaling":[140],"clusters.":[141],"Furthermore,":[142],"unclustered":[143],"Fc":[147],"applied":[148],"combination":[150],"initiate":[151],"greatly":[152],"enhanced":[153],"signaling.":[155],"Radiometal":[156],"conjugates":[157],"retain":[162],"affinity,":[164],"mouse":[167],"xenografts":[168],"localize":[169],"to,":[170],"are":[172],"internalized":[173],"rapidly":[174],"into":[175],"EphA3-positive,":[176],"tumors.":[178],"These":[179],"findings":[180],"biological":[183],"importance":[184],"EphA3/ephrin-A5":[186],"interactions":[187],"have":[193],"great":[194],"as":[196],"targeting":[198],"reagents.":[199]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-03-31T00:00:00"}